Health Policy and Planning; 15(2): 157-163
© Oxford University Press
2000
The Chinese experience of hospital price regulation
1 Institute of Social Medicine and Health Policy, Shandong Medical University, Jinan, China, and
2 Program in Health Care Financing at the Harvard School of Public Health, Cambridge, USA
This paper analyzes the distortion effects of the hospital pricing policies in China. To help maintain equitable access to hospital services, the Chinese government regulates prices of hospital services, and provides subsidies to public hospitals. Comparing the regulated fees of selected hospital services with their average unit costs indicates that the average cost-recovery rate of the fees is only 50%. The fees for 90% of the services are less than their average unit costs, while the fees for the high-tech services exceed their costs. Moreover, the State Price Commission allowed a drug profit margin of 15–20% over the wholesale price. The distorted fee schedule affects the behaviour of hospitals. Empirical evidence revealed problems of violation of price regulations (charging a fee exceeding the regulated fee), over-provision of profitable high-tech services and over-prescription of drugs. The Chinese experience shows that low regulated fees cannot reduce the economic burden on patients, and that distorted medical fees can result in distorted service provision and low efficiency of medical resources. Strategies to correct for the price distortions are discussed.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Reynolds and M. McKee Matching supply and demand for blood in Guizhou province, China: an unresolved challenge J. Public Health Med., April 20, 2009; (2009) fdp030v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Sun, M. A. Santoro, Q. Meng, C. Liu, and K. Eggleston Pharmaceutical Policy In China Health Aff., July 1, 2008; 27(4): 1042 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Hong Why is the Rate of Cesarean Section in Urban China so High? Is the Price Transparency Policy Working? Journal of Health Management, January 1, 2008; 10(1): 25 - 47. [Abstract] [PDF]
|
|
|
|
|
|
H. H. Dib, S. Y. Hong, Z. Bin, and S. Hongliang Health Care Costs in China: Need for Intervention Journal of Health Management, January 1, 2007; 9(1): 85 - 103. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Blumenthal and W. Hsiao Privatization and Its Discontents -- The Evolving Chinese Health Care System N. Engl. J. Med., September 15, 2005; 353(11): 1165 - 1170. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Burke, Y.-Y. Wong, and Z. Clayson Traditional Medicine in China Today: Implications for Indigenous Health Systems in a Modern World Am J Public Health, July 1, 2003; 93(7): 1082 - 1084. [Full Text] [PDF]
|
|